9-Chloro-2-(2-furyl)-(1,2,4)triazolo(1,5-c)quinazolin-5-imine (BioDeep_00000842034)

   


代谢物信息卡片


9-Chloro-2-(2-furyl)-(1,2,4)triazolo(1,5-c)quinazolin-5-imine

化学式: C13H8ClN5O (285.0417348)
中文名称:
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: C1=COC(=C1)C2=NN3C(=N2)C4=C(C=CC(=C4)Cl)N=C3N
InChI: InChI=1S/C13H8ClN5O/c14-7-3-4-9-8(6-7)12-17-11(10-2-1-5-20-10)18-19(12)13(15)16-9/h1-6H,(H2,15,16)

描述信息

CGS 15943 is an orally bioavailable non-xanthine Adenosine Receptor antagonist. Its Ki for human A1, A2A, A2B, and A3 Adenosine Receptors are 3.5, 4.2, 16, and 50 nM in transfected CHO cells, respectively. [1][2].

同义名列表

2 个代谢物同义名

9-Chloro-2-(2-furyl)-(1,2,4)triazolo(1,5-c)quinazolin-5-imine; CGS 15943



数据库引用编号

6 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：

  • PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。



文献列表

  • Mark J Henderson, Kathleen A Trychta, Shyh-Ming Yang, Susanne Bäck, Adam Yasgar, Emily S Wires, Carina Danchik, Xiaokang Yan, Hideaki Yano, Lei Shi, Kuo-Jen Wu, Amy Q Wang, Dingyin Tao, Gergely Zahoránszky-Kőhalmi, Xin Hu, Xin Xu, David Maloney, Alexey V Zakharov, Ganesha Rai, Fumihiko Urano, Mikko Airavaara, Oksana Gavrilova, Ajit Jadhav, Yun Wang, Anton Simeonov, Brandon K Harvey. A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome. Cell reports. 2021 04; 35(4):109040. doi: 10.1016/j.celrep.2021.109040. [PMID: 33910017]
  • Eszter Kozma, P Suresh Jayasekara, Lucia Squarcialupi, Silvia Paoletta, Stefano Moro, Stephanie Federico, Giampiero Spalluto, Kenneth A Jacobson. Fluorescent ligands for adenosine receptors. Bioorganic & medicinal chemistry letters. 2013 Jan; 23(1):26-36. doi: 10.1016/j.bmcl.2012.10.112. [PMID: 23200243]
  • John A Auchampach, Laura M Kreckler, Tina C Wan, Jason E Maas, Dharini van der Hoeven, Elizabeth Gizewski, Jayashree Narayanan, Garren E Maas. Characterization of the A2B adenosine receptor from mouse, rabbit, and dog. The Journal of pharmacology and experimental therapeutics. 2009 Apr; 329(1):2-13. doi: 10.1124/jpet.108.148270. [PMID: 19141710]
  • Matthew L Bilodeau, Ming Ji, Maryline Paris, Ourania M Andrisani. Adenosine signaling promotes neuronal, catecholaminergic differentiation of primary neural crest cells and CNS-derived CAD cells. Molecular and cellular neurosciences. 2005 Jul; 29(3):394-404. doi: 10.1016/j.mcn.2005.03.006. [PMID: 15886017]
  • Soo-Kyung Kim, Zhan-Guo Gao, Philippe Van Rompaey, Ariel S Gross, Aishe Chen, Serge Van Calenbergh, Kenneth A Jacobson. Modeling the adenosine receptors: comparison of the binding domains of A2A agonists and antagonists. Journal of medicinal chemistry. 2003 Nov; 46(23):4847-59. doi: 10.1021/jm0300431. [PMID: 14584936]
  • Bishop F Hague, Tong Mao Zhao, Thomas J Kindt. Binding of HTLV-1 virions to T cells occurs by a temperature and calcium-dependent process and is blocked by certain type 2 adenosine receptor antagonists. Virus research. 2003 May; 93(1):31-9. doi: 10.1016/s0168-1702(03)00048-0. [PMID: 12727340]
  • Andreas Kribben, Thorsten Feldkamp, Markus Horbelt, Bettina Lange, Frank Pietruck, Stefan Herget-Rosenthal, Uwe Heemann, Thomas Philipp. ATP protects, by way of receptor-mediated mechanisms, against hypoxia-induced injury in renal proximal tubules. The Journal of laboratory and clinical medicine. 2003 Jan; 141(1):67-73. doi: 10.1067/mlc.2003.7. [PMID: 12518170]
  • Lazaros C Foukas, Nathalie Daniele, Chariklia Ktori, Karen E Anderson, Jorgen Jensen, Peter R Shepherd. Direct effects of caffeine and theophylline on p110 delta and other phosphoinositide 3-kinases. Differential effects on lipid kinase and protein kinase activities. The Journal of biological chemistry. 2002 Oct; 277(40):37124-30. doi: 10.1074/jbc.m202101200. [PMID: 12145276]
  • K A Jacobson, Z G Gao, A Chen, D Barak, S A Kim, K Lee, A Link, P V Rompaey, S van Calenbergh, B T Liang. Neoceptor concept based on molecular complementarity in GPCRs: a mutant adenosine A(3) receptor with selectively enhanced affinity for amine-modified nucleosides. Journal of medicinal chemistry. 2001 Nov; 44(24):4125-36. doi: 10.1021/jm010232o. [PMID: 11708915]
  • X Ji, Y C Kim, D G Ahern, J Linden, K A Jacobson. [3H]MRS 1754, a selective antagonist radioligand for A(2B) adenosine receptors. Biochemical pharmacology. 2001 Mar; 61(6):657-63. doi: 10.1016/s0006-2952(01)00531-7. [PMID: 11266650]
  • X D Ji, K A Jacobson. Use of the triazolotriazine [3H]ZM 241385 as a radioligand at recombinant human A2B adenosine receptors. Drug design and discovery. 1999 Nov; 16(3):217-26. doi: NULL. [PMID: 10624567]
  • Y C Kim, M de Zwart, L Chang, S Moro, J K von Frijtag Drabbe Künzel, N Melman, A P IJzerman, K A Jacobson. Derivatives of the triazoloquinazoline adenosine antagonist (CGS 15943) having high potency at the human A2B and A3 receptor subtypes. Journal of medicinal chemistry. 1998 Jul; 41(15):2835-45. doi: 10.1021/jm980094b. [PMID: 9667972]
  • K Varani, B Cacciari, P G Baraldi, S Dionisotti, E Ongini, P A Borea. Binding affinity of adenosine receptor agonists and antagonists at human cloned A3 adenosine receptors. Life sciences. 1998; 63(5):PL 81-7. doi: 10.1016/s0024-3205(98)00289-6. [PMID: 9714428]
  • J Cooper, S J Hill, S P Alexander. An endogenous A2B adenosine receptor coupled to cyclic AMP generation in human embryonic kidney (HEK 293) cells. British journal of pharmacology. 1997 Oct; 122(3):546-50. doi: 10.1038/sj.bjp.0701401. [PMID: 9351513]
  • J J Reeves, C A Jones, M J Sheehan, C J Vardey, C J Whelan. Adenosine A3 receptors promote degranulation of rat mast cells both in vitro and in vivo. Inflammation research : official journal of the European Histamine Research Society ... [et al.]. 1997 May; 46(5):180-4. doi: 10.1007/s000110050169. [PMID: 9197988]
  • M F Ethier, J G Dobson. Adenosine stimulation of DNA synthesis in human endothelial cells. The American journal of physiology. 1997 Mar; 272(3 Pt 2):H1470-9. doi: 10.1152/ajpheart.1997.272.3.h1470. [PMID: 9087626]
  • Y C Kim, X D Ji, K A Jacobson. Derivatives of the triazoloquinazoline adenosine antagonist (CGS15943) are selective for the human A3 receptor subtype. Journal of medicinal chemistry. 1996 Oct; 39(21):4142-8. doi: 10.1021/jm960482i. [PMID: 8863790]
  • B B Fredholm, Y Zhang, I van der Ploeg. Adenosine A2A receptors mediate the inhibitory effect of adenosine on formyl-Met-Leu-Phe-stimulated respiratory burst in neutrophil leucocytes. Naunyn-Schmiedeberg's archives of pharmacology. 1996 Aug; 354(3):262-7. doi: 10.1007/bf00171056. [PMID: 8878055]
  • A M van Rhee, S M Siddiqi, N Melman, D Shi, W L Padgett, J W Daly, K A Jacobson. Tetrahydrobenzothiophenone derivatives as a novel class of adenosine receptor antagonists. Journal of medicinal chemistry. 1996 Jan; 39(2):398-406. doi: 10.1021/jm9504823. [PMID: 8558508]
  • J Kim, J Wess, A M van Rhee, T Schöneberg, K A Jacobson. Site-directed mutagenesis identifies residues involved in ligand recognition in the human A2a adenosine receptor. The Journal of biological chemistry. 1995 Jun; 270(23):13987-97. doi: 10.1074/jbc.270.23.13987. [PMID: 7775460]
  • F Suzuki, J Shimada, H Mizumoto, A Karasawa, K Kubo, H Nonaka, A Ishii, T Kawakita. Adenosine A1 antagonists. 2. Structure-activity relationships on diuretic activities and protective effects against acute renal failure. Journal of medicinal chemistry. 1992 Aug; 35(16):3066-75. doi: 10.1021/jm00094a022. [PMID: 1501234]
  • B C Abels, J T Callis, R A Branch, R Sabra. Influence of the adenosine receptor antagonist, CGS 15943A, on renal function after reconstruction of chronic renal artery stenosis in the dog. The Journal of pharmacology and experimental therapeutics. 1992 Jul; 262(1):166-72. doi: NULL. [PMID: 1625197]
  • W F Brubaker, E D Williams. Rapid, high-sensitivity reversed-phase liquid chromatographic assay for 9-chloro-2-(2-furyl) [1,2,4]triazolo[1,5-c]quinazolin-5-imine and its oxo metabolite in plasma using fluorescence detection. Journal of chromatography. 1989 Nov; 496(2):377-86. doi: 10.1016/s0378-4347(00)82585-2. [PMID: 2613841]